|
시장보고서
Latin American Cardiovascular Drugs Markets
|
Abstract
This research service covers the Latin America Cardiovascular drugs market
from 2004 to 2011, with 2006 as the base year. Major markets were studied:
Brazil and the Andean Region (which includes Colombia and Venezuela, countries
that are estimated to achieve double digit growth rates in the forecast
period).
Table of Contents
1. MARKET OVERVIEW
Introduction
- Executive Summary
- Research Scope and Methodology
- Market Segmentation
- Glossary of Terms
Overview
- Overview of the Latin American Cardiovascular Drugs Markets
- Market Engineering Measurements
- Regulatory Framework
2. CARDIOVASCULAR DRUGS MARKETS IN BRAZIL
Market Measurements
- Market Profile and Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
Antihypertensive Drugs
- Product Measurements
- Product Pricing Analysis
- Competitive Analysis
Antidyslipidemic Drugs
- Product Measurements
- Product Pricing Analysis
- Competitive Analysis
Other Drugs (Antithrombotics and Antiarrhythmics)
- Product Measurements
- Product Pricing Analysis
- Competitive Analysis
Product Distribution Analysis
- Product Distribution Structure
Drug Pipelines
3. CARDIOVASCULAR DRUGS MARKETS IN THE ANDEAN REGION (COLOMBIA AND VENEZUELA)
Market Measurements
- Market Profile and Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
Antihypertensive Drugs
- Product Measurements
- Product Pricing Analysis
- Competitive Analysis
Antidyslipidemic Drugs
- Product Measurements
- Product Pricing Analysis
- Competitive Analysis
Other Drugs (Antithrombotics and Antiarrhythmics)
- Product Measurements
- Product Pricing Analysis
- Competitive Analysis
Product Distribution Analysis
- Product Distribution Structure
Drug Pipelines
4. DECISION SUPPORT DATABASE
Decision Support Database
- Total Healthcare Expenditure
- Government Healthcare Expenditure
- Private Healthcare Expenditure
- Per Capita Healthcare Expenditure
- Pharmaceutical R&D Expenditure
- Prevalence of Hypertension
|
